17beta-Hydroxysteroid Dehydrogenase 14 inhibitors (ElexoPharma/German Research Center for Environmental Health/Philipps-Universitat Marburg)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name17beta-Hydroxysteroid Dehydrogenase 14 inhibitors (ElexoPharma/German Research Center for Environmental Health/Philipps-Universitat Marburg)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action17-hydroxysteroid dehydrogenases inhibitors
Targets17-hydroxysteroid dehydrogenases
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElexoPharm Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz Zentrum MuenchenElexoPharm GmbhPhilipps-Universität Marburg
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A